Frost & Sullivan
Frost & Sullivan

The eConsent Conundrum

When a patient enrolls in a clinical trial, upfront documentation is required, including an informed consent form. Having consent via an electronic system not only makes it easier to view—one could read the forms and may sign them ahead of time from the comfort of their home—but also contribute to a more electronically-centered trial process for data collection purposes, reduce compliance risk of outdated forms, and save sponsors significant costs associated with delayed trials.

While eConsent has been successful in facilitating the clinical trial enrollment process, it requires an upfront investment of time and training. Sponsors can increase adoption of eConsent by citing case studies and partnering with eClinical solution providers to equip trial sites with the latest software.

Download this complimentary article to discover:

  • The increasing use of eConsent in clinical trials
  • Challenges in adopting eConsent in clinical trials
  • Benefits of adopting eConsent in clinical trials

Download the Complimentary Article

"*" indicates required fields


This article is co-hosted in partnership with Frost & Sullivan and Castor. As a result, both Castor and Frost & Sullivan are collecting your personal data when you submit such information as part of the registration process above. For more information on each party’s privacy practices, please see: Castor Privacy Statement | Frost & Sullivan Privacy Notice.

The company can notify me about products, services, and events.
This field is for validation purposes and should be left unchanged.